Resources
2 Results (showing 1 - 2)
Results sorted by updated date (newest first)
Results sorted by updated date (newest first)
Posted 11/19/2019 (updated 3/28/2024)
This document provides scientific, evidence-based recommendations to protect yourself from exposure.
Posted 1/17/2023 (updated 3/27/2024)
The Consolidated Appropriations Act of 2023 removed the federal requirement for providers to have an X-waiver to prescribe medications for the treatment of OUD. The act amended the Controlled Substances Act. Depending on state law, practitioners who have a current DEA registration with Schedule III authority will be able to prescribe buprenorphine for OUD starting now.